EU Business Round-Up: Galderma Divests To Dallman’s, Oysershell names CEO, Ceres Acquires
Latest business news in the EU: Galderma offloads German Bübchen brand to Dallman's; Belgium's Oystershell names experienced CEO; Ceres Pharma snaps up Romania's Viva.
You may also be interested in...
After an almost 50% rise in sales in March, Germany's OTC market suffered a severe contraction in April as the 'boom' effect of the coronavirus wore off, according to data from Sempora Consulting.
Amophar has snapped up Belgian player Patch Pharma and at the same time launched the first pharmacy-only CBD available in the country.
After working hard to turnaround its troubled Skin Health dermatology operation, Nestlé looks set to offload the business to a consortium of private-equity buyers. The consortium - led by EQT - have identified expansion in the US consumer health market as an immediate priority.